Market Research Logo

United Kingdom Pharmaceuticals and Healthcare Report Q2 2015


Attention: There is an updated edition available for this report.

United Kingdom Pharmaceuticals and Healthcare Report Q2 2015

BMI View: The ageing population will have an unprecedented impact on the demand of healthcare and therapeutics in the UK. On the pharmaceutical front, the UK is a key international player, and will continue to be for the foreseeable future. However, the climate of cost containment, coupled with patent expirations, will lower the overall value of the UK's drug market.

Headline Expenditure Projections

Pharmaceutical spending is set to rise from GBP24.63bn (USD40.89bn) in 2014 to GBP24.75bn (USD39.84bn) in 2015, up 0.47% in local currency terms and down 2.6% in US dollar terms.

Healthcare spending will rise from GBP152.01bn (USD252.34bn) in 2014 to GBP155.51bn (USD250.36bn) in 2015, up 2.3% in local currency terms and 0.8% in dollar terms.


BMI Industry View
SWOT
Political
Economic
Operational Risk
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (United Kingdom 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (United Kingdom 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019)
OTC Medicines Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (United Kingdom 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (United Kingdom 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts (United Kingdom 2013-2019, GBP)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Risks To Outlook
Table: GDP By Expenditure (United Kingdom 2012-2019)
Industry Risk Reward Index
Western Europe Risk/Reward Index
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Recent Healthcare Sector Developments
Healthcare Insurance
Research And Development
Clinical Trials
Regulatory Development
Pharmaceutical Advertising
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Competitive Landscape
Pharmaceutical Industry
Table: Top 20 UK-Based Pharmaceutical Companies By Market Capitalisation
Table: Top 20 UK-Based Biotechnology Companies By Market Capitalisation
Recent Company Developments
Pharmaceutical Wholesale Sector
Pharmaceutical Retail Sector
Table: UK-Registered Retail Pharmacies, 2010
Company Profile
GlaxoSmithKline
AstraZeneca
Pfizer
Novartis
Sanofi
Merck & Co
Demographic Forecast
Table: Population Headline Indicators (United Kingdom 1990-2025)
Table: Key Population Ratios (United Kingdom 1990-2025)
Table: Urban/Rural Population & Life Expectancy (United Kingdom 1990-2025)
Table: Population By Age Group (United Kingdom 1990-2025)
Table: Population By Age Group % (United Kingdom 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report